Although SFRP2 was shown to act as tumor suppressor in CRC cell lines and SFRP2 methylation is a hallmark of CRC tumor cells, the clinical prognosis of SFRP2 methylation is contradictory. The gene discussed is SFRP2; the disease is neoplasm.